Patents by Inventor André Arsenault

André Arsenault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • In vitro mitochondrial function test (MFT) and uses thereof
    Patent number: 9581600
    Abstract: The present document describes an in vitro method for determining a level of mitochondrial function from a subject by determining a change in a labeled compound labeling a viable cell or tissue sample isolated from a subject following introduction of a volume of a solution over said viable cell or tissue sample. The comparison of the change to a normal reference is indicative of mitochondrial function in the subject.
    Type: Grant
    Filed: December 9, 2011
    Date of Patent: February 28, 2017
    Inventor: André Arsenault
  • IN VITRO MITOCHONDRIAL FUNCTION TEST (MFT) AND USES THEREOF
    Publication number: 20130280753
    Abstract: The present document describes an in vitro method for determining a level of mitochondrial function from a subject by determining a change in a labeled compound labeling a viable cell or tissue sample isolated from a subject following introduction of a volume of a solution over said viable cell or tissue sample. The comparison of the change to a normal reference is indicative of mitochondrial function in the subject.
    Type: Application
    Filed: December 9, 2011
    Publication date: October 24, 2013
    Inventor: André Arsenault
  • Non-invasive detection of endothelial dysfunction by blood flow measurement in opposed limbs using tracer injection
    Patent number: 6445945
    Abstract: Endothelial dysfunction is a known indicator of cornary artery disease. Endothelial dysfunction is detected by measuring tracer presence in arteries following the release of blood flow into the limb after a period of blockage of blood flow into the limb. The blood flow is measured in a pair of laterally opposed limbs, such as the patient's forearms, and the tracer presence is compared between both limbs. An efficient tracer is a radionuclide and the non-invasive measurement of the radionuclide is carried out by gamma ray detection.
    Type: Grant
    Filed: June 26, 2000
    Date of Patent: September 3, 2002
    Assignees: Institut de Cardiologie de Montreal
    Inventor: André Arsenault